CN1579627A - Chiral ligand metal complex catalyst system, and its preparation method and use - Google Patents

Chiral ligand metal complex catalyst system, and its preparation method and use Download PDF

Info

Publication number
CN1579627A
CN1579627A CN 03152667 CN03152667A CN1579627A CN 1579627 A CN1579627 A CN 1579627A CN 03152667 CN03152667 CN 03152667 CN 03152667 A CN03152667 A CN 03152667A CN 1579627 A CN1579627 A CN 1579627A
Authority
CN
China
Prior art keywords
diphenol
solids
reaction
ligand
och3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 03152667
Other languages
Chinese (zh)
Inventor
郑卓
黄汉民
陈惠麟
罗会礼
白长敏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian Institute of Chemical Physics of CAS
Original Assignee
Dalian Institute of Chemical Physics of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian Institute of Chemical Physics of CAS filed Critical Dalian Institute of Chemical Physics of CAS
Priority to CN 03152667 priority Critical patent/CN1579627A/en
Priority to PCT/CN2004/000777 priority patent/WO2005011863A1/en
Publication of CN1579627A publication Critical patent/CN1579627A/en
Pending legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/18Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
    • B01J31/1845Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing phosphorus
    • B01J31/185Phosphites ((RO)3P), their isomeric phosphonates (R(RO)2P=O) and RO-substitution derivatives thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/60Reduction reactions, e.g. hydrogenation
    • B01J2231/64Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
    • B01J2231/641Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
    • B01J2231/643Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes of R2C=O or R2C=NR (R= C, H)
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/60Reduction reactions, e.g. hydrogenation
    • B01J2231/64Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
    • B01J2231/641Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
    • B01J2231/645Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes of C=C or C-C triple bonds
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/02Compositional aspects of complexes used, e.g. polynuclearity
    • B01J2531/0261Complexes comprising ligands with non-tetrahedral chirality
    • B01J2531/0266Axially chiral or atropisomeric ligands, e.g. bulky biaryls such as donor-substituted binaphthalenes, e.g. "BINAP" or "BINOL"
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/02Compositional aspects of complexes used, e.g. polynuclearity
    • B01J2531/0269Complexes comprising ligands derived from the natural chiral pool or otherwise having a characteristic structure or geometry
    • B01J2531/0272Complexes comprising ligands derived from the natural chiral pool or otherwise having a characteristic structure or geometry derived from carbohydrates, including e.g. tartrates or DIOP
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82Metals of the platinum group
    • B01J2531/822Rhodium

Abstract

The invention relates to chirality phosphine ligand metal complex catalyse system, which is composed by complex formed by ligand and metal Rh, Ru, Ir, Pt or Pd or ligand and metal precursor in of 1-2 mol ratio. The phosphine ligand is a kind of effective chirality phosphate ligand composed by D-mannitol or L-mannitol after reaction. The catalyst composed by the chirality ligand and rhodium metallic compound in asymmetry hydrogenation reaction can work in room temperature. With a wide applied range, catalyst's activation and stereoselectivity is not influenced from normal pressure to high pressure. Reaction time is 1-24 hours. Mol ratio of ligand and metal rhodium compound is 1:1-2:1. Ratio of reactant and catalyst is 100-10,000.

Description

A kind of chiral ligand metal complex to catalyze system and method for making and application
Technical field
The present invention relates to a kind of chiral ligand metal complex to catalyze system;
The invention still further relates to the preparation method of above-mentioned catalyst system and catalyzing;
The invention still further relates to the application of above-mentioned catalyst system and catalyzing in asymmetric hydrogenation.
Background technology
The catalysis asymmetric hydrogenation is the core technology in the asymmetric syntheses, is one of most effectual way of synthesizing optical homochiral medicine, agricultural chemicals, food additives, spices, and the design of chiral ligand synthetic be the key factor that realizes this core technology.At present, existing many chirality bidentate phosphine ligandses are developed by people in succession, but because the synthetic difficulty of most parts is big, poor stability, synthetic costing an arm and a leg is difficult to be applied in the industrial production, and therefore real to be successfully applied to industrial chiral phosphine ligand few.The DIPAMP that U.S. Monsanto Company is only arranged that is used for commercial Application of present bibliographical information, several classes that the BINAP of Japanese high sand spices etc. are very few.Recently, monodentate chirality phosphite ester, phosphoramidite class part are also developed by people in succession, though this type of part is synthetic easy, Stability Analysis of Structures, but the chiral induction ability of this type of part, the ligand substrate scope of application is narrow, has also limited it in industrial application.
Summary of the invention
The object of the present invention is to provide a kind of chiral ligand metal complex to catalyze system;
Another purpose of the present invention is to provide the preparation method of above-mentioned catalyst system and catalyzing, specifically the preparation method of part in the catalyst system and catalyzing.
Chiral ligand metal complex to catalyze system provided by the invention, the system that complex compound that is formed by part and metal Rh, Ru, Ir, Pt or Pd or part and respective metal precursor are formed by 1~2 mol ratio; Wherein part has following structure and structural formula title:
Or
Wherein, the R in the part 1, R 2Group is: the C of hydrogen, phenyl, substituted-phenyl, 1-naphthyl or 2-naphthyl 6-C 60In contain N, S, O, P or do not contain the aromatic group of N, S, O, P; The C of methyl, ethyl, propyl group or butyl 1~C 40The interior fat group that contains N, S, O, P;
In the part
Figure A0315266700053
Group is:
Wherein: R=HR=CH3R=Ph
Figure A0315266700055
Wherein: R1=CH3 R2=HR1=CH3 R2=CH3R1=OCH3 R2=HR1=OCH 3R2=CH3 Wherein: R1=CH3 R2=H, R2=CH3 R1=H, R1=CH3 R2=CH3, R1=Ph R2=H, R1=OCH3 R2=H, R2=OCH3 R1=H, R1=OCH 3R2=CH3, R2=OCH 3R1=CH3, R1=t-Bu R2=t-Bu, R1=Si ( CH 3) 3 R2=H, R1=t-Bu R2=H, R2=t-Bu R1=H,
The present invention prepares the method for part in the above-mentioned catalyst system and catalyzing, is that chiral source is synthesized a kind of phosphite ester ligand of chirality efficiently through three-step reaction with D-type sweet mellow wine or L-type sweet mellow wine, and the structure of part and synthetic technology route are as follows:
Or
Wherein:
In the first step reaction, aldehyde: sweet mellow wine: the concentrated sulfuric acid (mol ratio) is 1: 4.4: 2;
In the reaction of second step, material (1): NaH: RX (mol ratio)=l: 1: 1.1;
In the three-step reaction, material (2): diphenol: PCl 3: EtZ 3N (mol ratio)=1: 1.2: 1: 2.2.
Specifically, the preparation process of part is in the catalyst system and catalyzing:
A) aldehyde in molar ratio: sweet mellow wine: the concentrated sulfuric acid is 1: 4.4: 2, join in the solvent DMF that equates with above-mentioned cumulative volume, reaction is 10-80 hour under the stirring at room, the reactant mixture filtration is obtained solid and uses petroleum ether, the solids chloroform extracting of boiling, the solids that filtration obtains is through recrystallizing methanol;
B) solids that step 1 is obtained, sodium hydride and halogenated aliphatic hydrocarbon are to join in DMF at 1: 1: 1.1 in molar ratio, under the room temperature stirring reaction 0.5-3 hour, reactant mixture extracted with diethyl ether, saline solution washing, anhydrous sodium sulfate drying is removed solvent and is obtained solids;
C) under the nitrogen protection, will poly-2 solids that obtain of step drip triethylamine in 0-5 ℃, dropwise the back, add diphenol again under room temperature stirring reaction 1-3 hour, filter, remove solvent and obtain required part through the ether recrystallization stirring at room reaction 5-30 minute; Mol ratio in this step is a solids: diphenol: phosphorus trichloride (PCl 3): triethylamine=1: 1.2: l: 2.2.
Aldehyde used among described preparation method's step a is C 1-C 60Fatty aldehyde or C 6-C 30Aromatic aldehyde;
Used aldehyde is formaldehyde, acetaldehyde or benzaldehyde among described preparation method's step a.
Used halogenated aliphatic hydrocarbon is that iodomethane, aromatic hydrocarbons replace halogenated methyl, aromatic hydrocarbons replaces halogenated methylene or aromatic hydrocarbons replaces the halo methine among described preparation method's step b.
Used diphenol is 2 among described preparation method's step c, 2 '-dinaphthalene diphenol, 3,2 of 3 ' replacement, 2 '-dinaphthalene diphenol, 2,2 of 2 '-'-biphenyl diphenol or replacement, 2 '-'-biphenyl diphenol.
Chiral phosphine ligand ManniPhos of the present invention and metal precursor original position form metal complex the hydrogenation of C=C key, C=N key, C=O key is had high catalytic activity and optical selective.Be reflected at 1-100atm, carry out under-20~200 ℃ the temperature, can select the alcohols solvent of protic for use, also can select the C of non-proton property according to raw material types 6~C 10Alkane, CH 2Cl 2, CH 2ClCH 2Cl, CH 3Cl, CCl 4, oxolane etc. makes solvent.
Figure A0315266700071
The invention effect
It is applied widely that the present invention designs the catalyst that synthetic chiral ligand ManniPhos and rhodium metal compound form, and can be applied to the asymmetric hydrogenation of the two keys of multiclass C=C.ManniPhos and [Rh (COD) 2] BF 4The catalyst that forms under the condition is mainly used in following a few class substrate catalysis asymmetry hydrogenation reaction in position:
(1) catalysis asymmetry hydrogenation reaction of α-dehydroamino acid;
(2) catalysis asymmetry hydrogenation reaction of β-dehydroamino acid;
(3) catalysis asymmetry hydrogenation reaction of the itaconic acid compounds of itaconic acid and β-replacement thereof;
(4) catalysis asymmetry hydrogenation reaction of alpha-substituted non-annularity and ring-type enamine.
The chiral ligand ManniPhos of the present invention's design is to air-stable, easy operating, preservation; The part synthesis route is simple, need not high temperature in the building-up process, violent operating condition such as high pressure; Part is synthetic with low cost, and synthesis material sweet mellow wine, aldehyde, phosphorus trichloride etc. cheaply are easy to get.The catalyst stereoselectivity height that ManniPhos and rhodium metal compound form, enantio-selectivity all can be up to 99.9% for above four class substrates; The catalyst activity height that ManniPhos and rhodium metal compound form, TON can be up to 10,000.
The present invention designs the asymmetric hydrogenation mild condition of the catalyst participation of synthetic chiral ligand ManniPhos and the formation of rhodium metal compound, can at room temperature react; The force applications scope of hydrogen is wide, does not all influence activity of such catalysts from the normal pressure to the high pressure, stereoselectivity, and the reaction time is 1~24 hour, and the mol ratio of part and metal rhodium compound is 1: 1~4: 1, and reaction substrate is 100~10,000 with the ratio of catalyst.
Chiral monophosphorus ligand ManniPhos proposed by the invention has characteristics such as synthetic route is simple, cost is low, stable in the air, and its metal Rh, Ru, Ir, Pd, Pt complex compound have high catalytic activity and optical selective to the hydrogenation reaction of C=C, C=O, C=N key.The catalyst that chiral ligand and rhodium metal compound form has high catalytic activity and stereoselectivity to the itaconic acid four class substrates of α-dehydroamino acid, β-dehydroamino acid, itaconic acid and β-replacement thereof, in temperature is 0~100 ℃, under the reaction condition of pressure 1~100atm, TON can be up to 10,000, enantio-selectivity can be up to 99.9%.Use this chiral ligand, can prepare polytype quiral products such as chiral drug, chirality agricultural chemicals, chiral amino acid by asymmetric hydrogenation, have important use in industries such as medicine, agricultural chemicals, spices, food and feed additives and be worth.
By comparison, though the monodentate phosphine ligand of existing Reetz etc. is synthetic fairly simple, the chemical property of part is stable, in air, can stablize and deposit, but a Rh complex compound activity to the itaconic acid analog derivative, enantioselectivity be (S/C=5000 better, e.e=99.6%), but to α-dehydroamino acid, eneamines, the β-activity of dehydroamino acids substrate, enantioselectivity is relatively poor or extreme difference.
The specific embodiment
(1) part is synthetic
Embodiment 1
Add the concentrated sulfuric acid (20ml) in the churned mechanically there-necked flask in having of 1000ml, D-sweet mellow wine (100g), benzaldehyde (120ml) and solvent DMF (300ml), this reactant mixture is after stirring at room is reacted 3 days, reactant mixture poured in the frozen water that contains 30 gram potash and 500ml benzinums into vigorous stirring up to ice-out, filtration obtains solid and uses petroleum ether, solids is with the chloroform extracting of 400ml boiling 2 times, the solids that filtration obtains can obtain product white solid 1 (86g, 42%) through recrystallizing methanol.
In the round-bottomed flask of a 250ml, add sodium hydride (12mmol, the sodium hydride that is melted into mineral oil of content 80%), last synthetic compound 1 (10mmol) of step, solvent DMF (40ml), at room temperature stirring reaction is after 1 hour with this reactant mixture, and adding iodomethane (10mmol) continues at room temperature to react 1 hour.Reactant mixture is with 20ml water dilution extracted with diethyl ether, the salt water washing of being satiated with food, anhydrous sodium sulfate drying is removed solvent through decompression and is obtained solids, through carrene/n-hexane be recrystallized white crystal 2 (3.54g, 95%).
Under nitrogen protection; have to add in the there-necked flask of dropping funel and stirring to 100ml and go up step synthetic compound (5mmol); drip phosphorus trichloride (5mmol) down at 0 ℃; dropwise that the recession deicing is bathed and in the stirring at room reaction after 1 hour; add triethylamine (15.5mmol) down in 0 ℃; dropwise that the recession deicing is bathed and stirring at room reaction 15 minutes, 2 of solid R type, 2 '-dinaphthalene diphenol (R-BINOL) joined in the reactant mixture under room temperature stirring reaction 1~3 hour.Add the ether dilution and help filter, remove solvent through decompression and obtain the foam-like solids, obtain white solid through the ether recrystallization and be required part (2.74g, 80%) with diatomite.
(2) catalysis asymmetry hydrogenation reaction
Embodiment 1
Under nitrogen protection, 2.0mg (0.005mmol) [Rh (COD) 2] BF 4With above-mentioned synthetic chiral ligand ManniPhos (0.010mmol), methylene chloride (1ml) is at room temperature in the reactor of 10ml, react and made catalyst in 10-30 minute, hydrogenation reaction substrate 2-acetamidoacrylic acid methyl esters (0.5mmol) is transferred in this reactor, continue to feed hydrogen behind the hydrogen exchange 3 times, keep synthesis under normal pressure cessation reaction after 30 minutes, filter with short silicagel column, to filter after gained filtrate concentrates, carry out content and optical purity mensuration with GC, get S-acetylamino methyl propionate yield 100% (in 2-acetamidoacrylic acid methyl esters), enantiomeric excess is 97.7%ee.
Embodiment 2
Under nitrogen protection, 2.0mg (0.005mmol) [Rh (COD) 2] BF 4With above-mentioned synthetic chiral ligand ManniPhos (0.010mmol), methylene chloride (1ml) is at room temperature in the reactor of 10ml, react and made catalyst in 10-30 minute, hydrogenation reaction substrate 2-acetylamino methyl cinnamate (0.5mmol) is transferred in this reactor, continue to feed hydrogen behind the hydrogen exchange 3 times, keep synthesis under normal pressure cessation reaction after 30 minutes, filter with short silicagel column, to filter after gained filtrate concentrates, carry out content and optical purity mensuration with GC, get S-acetylamino methyl phenylpropionate yield 100% (in 2-acetylamino methyl cinnamate), enantiomeric excess is 98.0%ee.
Embodiment 3
Under nitrogen protection, 2.0mg (0.005mmol) [Rh (COD) 2] BF 4With above-mentioned synthetic chiral ligand ManniPhos (0.010mmol), methylene chloride (1ml) is at room temperature in the reactor of 10ml, react and made catalyst in 10-30 minute, the precursor (0.5mmol) of hydrogenation reaction substrate DOPA is transferred in this reactor, continue to feed hydrogen behind the hydrogen exchange 3 times, keep synthesis under normal pressure cessation reaction after 30 minutes, filter with short silicagel column, to filter after gained filtrate concentrates, carry out content and optical purity mensuration with GC, get L-DOPA yield 100% (in the precursor of DOPA), enantiomeric excess is 98.0%ee.
Embodiment 4
Under nitrogen protection, 2.0mg (0.005mmol) [Rh (COD) 2] BF 4With above-mentioned synthetic chiral ligand ManniPhos (0.010mmol), methylene chloride (1ml) is at room temperature in the reactor of 10ml, react and made catalyst in 10-30 minute, hydrogenation reaction substrate dimethyl itaconate (0.5mmol) is transferred in this reactor, continue to feed hydrogen behind the hydrogen exchange 3 times, keep synthesis under normal pressure cessation reaction after 3 hours, filter with short silicagel column, to filter after gained filtrate concentrates, carry out content and optical purity mensuration with GC, get (R)-2-dimethyl succinic acid dimethyl ester 100% (in dimethyl itaconate), enantiomeric excess is 99.0%ee.
Embodiment 5
Under nitrogen protection, 2.0mg (0.005mmol) [Rh (COD) 2] BF 4With above-mentioned synthetic chiral ligand ManniPhos (0.010mmol), methylene chloride (1ml) is at room temperature in the reactor of 10ml, react and made catalyst in 10-30 minute, catalyst is transferred in the reactor, hydrogenation reaction substrate dimethyl itaconate (0.5mmol) joins in this reactor, continue to feed hydrogen behind the hydrogen exchange 3 times, keep 10 kilograms of stress reactions cessation reaction after 3 hours, filter with short silicagel column, will filter after gained filtrate concentrates, carry out content and optical purity mensuration with GC, get (R)-2-dimethyl succinic acid dimethyl ester 100% (in dimethyl itaconate), enantiomeric excess is 98.8%ee.
Embodiment 6
Under nitrogen protection, 2.0mg (0.005mmol) [Rh (COD) 2] BF 4With above-mentioned synthetic chiral ligand ManniPhos (0.010mmol), methylene chloride (1ml) is at room temperature in the reactor of 10ml, react and made catalyst in 10-30 minute, catalyst is transferred in the reactor, hydrogenation reaction substrate 2-acetylaminohydroxyphenylarsonic acid 2-M Cr (0.5mmol) joins in this reactor, continue to feed hydrogen behind the hydrogen exchange 3 times, keep 40 kilograms of stress reactions cessation reaction after 24 hours, filter with short silicagel column, to filter after gained filtrate concentrates, carry out content and optical purity mensuration with GC, get (S)-2-acetylaminohydroxyphenylarsonic acid 2-methyl butyrate 100% (in 2-acetylaminohydroxyphenylarsonic acid 2-M Cr), enantiomeric excess is 99.1%ee.
Embodiment 7
Under nitrogen protection, 2.0mg (0.005mmol) [Rh (COD) 2] BF 4With above-mentioned synthetic chiral ligand ManniPhos (0.010mmol), methylene chloride (1ml) is at room temperature in the reactor of 10ml, react and made catalyst in 10-30 minute, catalyst is transferred in the reactor, hydrogenation reaction substrate acetylamino styrene (0.5mmol) joins in this reactor, continue to feed hydrogen behind the hydrogen exchange 3 times, keep 10 kilograms of stress reactions cessation reaction after 3 hours, filter with short silicagel column, will filter after gained filtrate concentrates, carry out content and optical purity mensuration with GC, get (S)-acetylamino vinylbenzene 100% (in acetylamino styrene), enantiomeric excess is 99.8%ee.
Embodiment 8
Under nitrogen protection, 2.0mg (0.005mmol) [Rh (COD) 2] BF 4With above-mentioned synthetic chiral ligand ManniPhos (0.010mmol), methylene chloride (1ml) is at room temperature in the reactor of 10ml, react and made catalyst in 10-30 minute, hydrogenation reaction substrate 2-acetylamino styrene (0.5mmol) is transferred in this reactor, continue to feed hydrogen behind the hydrogen exchange 3 times, keep synthesis under normal pressure cessation reaction after 3 hours, filter with short silicagel column, to filter after gained filtrate concentrates, carry out content and optical purity mensuration with GC, get (S)-acetylamino vinylbenzene 100% (in 2-acetylamino styrene), enantiomeric excess is 99.8%ee.
Embodiment 9
Under nitrogen protection, 2.0mg (0.005mmol) [Rh (COD) 2] BF 4With above-mentioned synthetic chiral ligand ManniPhos (0.010mmol), methylene chloride (1ml) is at room temperature in the reactor of 10ml, react and made catalyst in 10-30 minute, catalyst is transferred in the reactor, hydrogenation reaction substrate acetylamino styrene (50mmol) and 20ml solvent join in this reactor, continue to feed hydrogen behind the hydrogen exchange 3 times, keep 10 kilograms of stress reactions cessation reaction after 6 hours, filter with short silicagel column, will filter after gained filtrate concentrates, carry out content and optical purity mensuration with GC, get (S)-acetylamino vinylbenzene 100% (in acetylamino styrene), enantiomeric excess is 96.0%ee.
Embodiment 10
Under nitrogen protection, 2.0mg (0.005mmol) [Ir (COD) 2] BF 4With above-mentioned synthetic chiral ligand ManniPhos (0.010mmol), methylene chloride (1ml) is at room temperature in the reactor of 10ml, react and made catalyst in 10-30 minute, catalyst is transferred in the reactor, hydrogenation reaction substrate phenylpropyl alcohol azomethine (0.5mmol) and 2ml solvent join in this reactor, continue behind the hydrogen exchange 3 times to feed hydrogen, keep 60 kilograms of stress reactions cessation reaction after 6 hours.Filter with short silicagel column, will filter after gained filtrate concentrates, carry out content and optical purity is measured with GC, get Phenpromethamine yield 100% (in the phenylpropyl alcohol azomethine), enantiomeric excess is 98.0%ee.
Embodiment 11
Under nitrogen protection; 2.0mg (0.005mmol) phellandrene ruthenic chloride; with above-mentioned synthetic chiral ligand ManniPhos (0.010mmol); methylene chloride (1ml) is at room temperature in the reactor of 10ml; react and made catalyst in 10-30 minute; catalyst is transferred in the reactor; hydrogenation reaction substrate methyl pyruvate (0.5mmol) and 2ml solvent join in this reactor; the hydrogenation substrate is transferred in this reactor; continue behind the hydrogen exchange 3 times to feed hydrogen, keep 60 kilograms of pressure in 60 ℃ of reactions cessation reaction after 6 hours.Filter with short silicagel column, will filter after gained filtrate concentrates, carry out content and optical purity is measured with GC, get S-methyl lactate yield 100% (in methyl pyruvate), enantiomeric excess is 99.0%ee.
Relevant comparative example 1
Press embodiment 1, the monodentate phosphinate part of use Reetz etc. is made the asymmetric hydrogenation of Rh catalyst α-dehydroamino acid ester, only can obtain 95.5%ee.
Figure A0315266700121
Relevant comparative example 2
Press embodiment 7, the monodentate phosphinate part of use Reetz etc. is made the asymmetric hydrogenation of the enamine of Rh catalyst, can only be at higher pressure, and 60atm reaction down, and only obtain 95.3%ee.

Claims (7)

1, a kind of chiral ligand metal complex to catalyze system, the system that complex compound that is formed by part and metal Rh, Ru, Ir, Pt or Pd metal or part and respective metal precursor are formed by 1~2 mol ratio; Wherein part has following structure and structural formula name:
Wherein, the R in the part 1, R 2Group is: the C of hydrogen, phenyl, substituted-phenyl, 1-naphthyl or 2-naphthyl 6-C 60The interior aromatic group that contains N, S, O, P; The C of methyl, ethyl, propyl group or butyl 1~C 40The interior fat group that contains N, S, O, P;
In the part
Figure A031526670002C2
Group is:
Wherein, R=HR=CH3R=Ph Wherein, R1=CH3 R2=HR1=CH3 R2=CH3R1=OCH3 R2=HR1=OCH3 R2=CH3 Wherein, R1=CH3 R2=H, R2=CH3 R1=H.R1=CH3 R2=CH3, R1=Ph R2=H.R1=OCH3 R2=H, R2=OCH3 R1=H.R1=OCH3 R2=CH3, R2=OCH3 R1=CH3, R1=t-Bu R2=1-Bu, R1=Si ( CH 3) 3 R2=H. R1=t-Bu R2=H, R2=1-Bu R1=H,
2, a kind of method for preparing part in the described catalyst system and catalyzing of claim 1 the steps include:
A) aldehyde in molar ratio: sweet mellow wine: the concentrated sulfuric acid is 1: 4.4: 2, join in the organic solvent that equates with above-mentioned cumulative volume, reaction is 10-80 hour under the stirring at room, the reactant mixture filtration is obtained solid and uses petroleum ether, the solids chloroform extracting of boiling, the solids that filtration obtains is through recrystallizing methanol;
B) solids that step 1 is obtained, sodium hydride and halogenated aliphatic hydrocarbon are to join in organic solvent at 1: 1: 1.1 in molar ratio, under the room temperature stirring reaction 0.5-3 hour, reactant mixture extracted with diethyl ether, saline solution washing, anhydrous sodium sulfate drying is removed solvent and is obtained solids;
C) under the nitrogen protection, will poly-2 solids that obtain of step drip triethylamine in 0-5 ℃, dropwise the back, add diphenol again under room temperature stirring reaction 1-3 hour, filter, remove solvent and obtain required part through the ether recrystallization stirring at room reaction 5-30 minute; Mol ratio in this step is a solids: diphenol: phosphorus trichloride: triethylamine=1: 1.2: 1: 2.2.
3, preparation method as claimed in claim 2 is characterized in that, aldehyde used among the step a is C 1-C 60Fatty aldehyde or C 6-C 30Aromatic aldehyde;
4, preparation method as claimed in claim 3 is characterized in that, used aldehyde is formaldehyde, acetaldehyde or benzaldehyde among the step a.
5, preparation method as claimed in claim 2 is characterized in that, used halogenated aliphatic hydrocarbon is that iodomethane, aromatic hydrocarbons replace halogenated methyl, aromatic hydrocarbons replaces halogenated methylene or aromatic hydrocarbons replaces the halo methine among the step b.
6, preparation method as claimed in claim 1 is characterized in that, used diphenol is 2 among the step c, 2 '-dinaphthalene diphenol, 3,2 of 3 ' replacement, 2 '-dinaphthalene diphenol, 2,2 of 2 '-'-biphenyl diphenol or replacement, 2 '-'-biphenyl diphenol.
7, the application of the described chiral monodentate phosphorus of above-mentioned each claim part asymmetric hydrogenation in C=C, C=O, C=N key.
CN 03152667 2003-08-05 2003-08-05 Chiral ligand metal complex catalyst system, and its preparation method and use Pending CN1579627A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN 03152667 CN1579627A (en) 2003-08-05 2003-08-05 Chiral ligand metal complex catalyst system, and its preparation method and use
PCT/CN2004/000777 WO2005011863A1 (en) 2003-08-05 2004-07-09 A chiral ligand metalcomplex catalyst system and its preparation and applications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 03152667 CN1579627A (en) 2003-08-05 2003-08-05 Chiral ligand metal complex catalyst system, and its preparation method and use

Publications (1)

Publication Number Publication Date
CN1579627A true CN1579627A (en) 2005-02-16

Family

ID=34109575

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 03152667 Pending CN1579627A (en) 2003-08-05 2003-08-05 Chiral ligand metal complex catalyst system, and its preparation method and use

Country Status (2)

Country Link
CN (1) CN1579627A (en)
WO (1) WO2005011863A1 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102532225A (en) * 2010-12-23 2012-07-04 中国科学院兰州化学物理研究所 Chiral phosphate ester ligand derived from methyl glucoside as well as preparation method and application thereof
CN106040299A (en) * 2016-05-30 2016-10-26 北京理工大学 Chiral diene rhodium metal catalyst and preparation method and application thereof
CN110963902A (en) * 2019-12-05 2020-04-07 万华化学集团股份有限公司 Method for synthesizing R-citronellal by water-oil two-phase asymmetric hydrogenation and catalyst used in method
CN111185241A (en) * 2020-03-09 2020-05-22 邯郸学院 Metal catalyst and preparation method and application thereof
CN111285773A (en) * 2018-12-10 2020-06-16 中国科学院大连化学物理研究所 Method for preparing chiral amine based on glucose-derived monodentate phosphite ligand asymmetric hydrogenation
CN111285774A (en) * 2018-12-10 2020-06-16 中国科学院大连化学物理研究所 Asymmetric imine hydrogenation method based on chiral monodentate phosphine ligand derived from D-mannitol
CN111978144A (en) * 2020-09-16 2020-11-24 河北凡克新材料有限公司 Preparation method of cyclohexyl polyfluorobenzene liquid crystal monomer
CN112876589A (en) * 2021-01-15 2021-06-01 万华化学集团股份有限公司 Organic polymer catalyst, preparation method thereof and application thereof in preparation of polyether polyol
CN113527367A (en) * 2021-07-14 2021-10-22 南开沧州渤海新区绿色化工研究有限公司 Chiral diphosphine ligand rhodium complex containing tetra (3, 5-bistrifluoromethylphenyl) boron anion and preparation method and application thereof
CN114573473A (en) * 2022-03-03 2022-06-03 浙江工业大学 Preparation method of (R) -alpha-aryl alanine ester derivative
CN114956979A (en) * 2022-06-06 2022-08-30 中国科学技术大学 Catalyst system for synthesizing phenylacetic acid from toluene

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111018818B (en) * 2019-12-16 2022-11-29 云南民族大学 Chiral phthalide compound and synthesis method of deuterated compound thereof
CN112044472B (en) * 2020-09-14 2023-03-17 哈尔滨工程大学 Chiral mesoporous amino acid polymer supported transition metal asymmetric catalyst and preparation method thereof
CN112538095B (en) * 2020-12-14 2022-08-05 万华化学集团股份有限公司 Chiral tetradentate ligand, chiral ruthenium complex and method for preparing (R) - (-) -1, 3-butanediol
CN114904577A (en) * 2022-05-17 2022-08-16 哈尔滨工程大学 Chiral porous cross-linked oligopeptide polymer asymmetric catalyst and preparation method thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1212254A (en) * 1997-09-25 1999-03-31 中国科学院兰州化学物理研究所 Method for preparing naproxen of methyl ester and S-(+) naproxen of methyl ester by using carbonylation
US5886182A (en) * 1997-12-10 1999-03-23 The Hong Kong Polytechnic University Chiral pyridylphosphines and their application in asymmetric catalytic hydrogenation of 2-arylpropenoic acids
DE19938709C1 (en) * 1999-08-14 2001-01-18 Boehringer Ingelheim Pharma Adrenaline or its addition salt is prepared on industrial scale with asymmetric hydrogenation as the key step and special sequence of successive steps using a rhodium and bidentate phosphine ligand catalyst system
AU2002241517A1 (en) * 2000-11-07 2002-06-18 Symyx Technologies, Inc. Methods of copolymerizing ethylene and isobutylene and polymers made thereby
ATE462709T1 (en) * 2001-07-23 2010-04-15 Wisconsin Alumni Res Found METHOD FOR PRODUCING DIAZAPHOSPHACYCLES
GB0120167D0 (en) * 2001-08-17 2001-10-10 Chirotech Technology Ltd Asymmetric hydrogenation
CN1166672C (en) * 2001-12-07 2004-09-15 中国科学院上海有机化学研究所 Metal complex of C2 uncymmetric chira biphosphine ligand, its synthesizing process and its application in unsymmetric catalytic hydrogenation of ketone
CN1166671C (en) * 2001-12-07 2004-09-15 中国科学院上海有机化学研究所 C2 unsymmetric chiral biphosphine ligand and its synthesizing method and application

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102532225A (en) * 2010-12-23 2012-07-04 中国科学院兰州化学物理研究所 Chiral phosphate ester ligand derived from methyl glucoside as well as preparation method and application thereof
CN106040299A (en) * 2016-05-30 2016-10-26 北京理工大学 Chiral diene rhodium metal catalyst and preparation method and application thereof
CN106040299B (en) * 2016-05-30 2020-10-23 北京理工大学 Chiral diene rhodium metal catalyst, preparation method and application
CN111285773A (en) * 2018-12-10 2020-06-16 中国科学院大连化学物理研究所 Method for preparing chiral amine based on glucose-derived monodentate phosphite ligand asymmetric hydrogenation
CN111285774A (en) * 2018-12-10 2020-06-16 中国科学院大连化学物理研究所 Asymmetric imine hydrogenation method based on chiral monodentate phosphine ligand derived from D-mannitol
CN110963902B (en) * 2019-12-05 2023-01-13 万华化学集团股份有限公司 Method for synthesizing R-citronellal by water-oil two-phase asymmetric hydrogenation and catalyst used in method
CN110963902A (en) * 2019-12-05 2020-04-07 万华化学集团股份有限公司 Method for synthesizing R-citronellal by water-oil two-phase asymmetric hydrogenation and catalyst used in method
CN111185241A (en) * 2020-03-09 2020-05-22 邯郸学院 Metal catalyst and preparation method and application thereof
CN111978144A (en) * 2020-09-16 2020-11-24 河北凡克新材料有限公司 Preparation method of cyclohexyl polyfluorobenzene liquid crystal monomer
CN112876589A (en) * 2021-01-15 2021-06-01 万华化学集团股份有限公司 Organic polymer catalyst, preparation method thereof and application thereof in preparation of polyether polyol
CN112876589B (en) * 2021-01-15 2022-04-22 万华化学集团股份有限公司 Organic polymer catalyst, preparation method thereof and application thereof in preparation of polyether polyol
CN113527367A (en) * 2021-07-14 2021-10-22 南开沧州渤海新区绿色化工研究有限公司 Chiral diphosphine ligand rhodium complex containing tetra (3, 5-bistrifluoromethylphenyl) boron anion and preparation method and application thereof
CN114573473A (en) * 2022-03-03 2022-06-03 浙江工业大学 Preparation method of (R) -alpha-aryl alanine ester derivative
CN114573473B (en) * 2022-03-03 2023-11-28 浙江工业大学 Preparation method of (R) -alpha-aryl alanine ester derivative
CN114956979A (en) * 2022-06-06 2022-08-30 中国科学技术大学 Catalyst system for synthesizing phenylacetic acid from toluene

Also Published As

Publication number Publication date
WO2005011863A1 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
CN1579627A (en) Chiral ligand metal complex catalyst system, and its preparation method and use
JP4958374B2 (en) Catalysts for asymmetric (mobile) hydrogenation
Takizawa et al. P-chirogenic organocatalysts: application to the aza-Morita–Baylis–Hillman (aza-MBH) reaction of ketimines
US6037500A (en) Asymmetric synthesis catalyzed by transition metal complexes with cyclic chiral phosphine ligands
CN1768944A (en) Catalyst using phosphine-phosphoramidite ester as ligand, its preparation method and application
EP0938488A1 (en) Phosphine ligands
KR101245065B1 (en) Hydrogenation of imines
US6255493B1 (en) Transition metal-catalyzed reactions based on chiral amine oxazolinyl ligands
CN1255375C (en) Industrial process for production of L-carnitine
CN101495491A (en) Process for production of optically active aminophosphinylbutanoic acid
US6583312B2 (en) Process for preparing optically active trimethyllactic acid and its esters
US6207868B1 (en) Asymmetric synthesis catalyzed by transition metal complexes with chiral ligands
US6613922B2 (en) Phosphorus p-cyclophane ligands and their use in transition metal catalyzed asymmetric reactions
Mi et al. Asymmetric Synthesis XXVIII: Novel Chiral Aminophosphine Phosphinite Ligand and Its Application in Homogenous Catalytic Asymmetric Hydrogenation of Dehydroamino Acid Derivatives
CN101085770B (en) Method for preparing t-butyl (3R, 5S)-3,5,6-trihydroxy-hexanoate
CN112824423B (en) Chiral ferrocenylphosphine-indolylaminophosphine ligand and preparation method and application thereof
Zhao et al. Synthesis of diphosphite ligands derived from glucopyranoside and their application in the Cu-catalyzed asymmetric 1, 4-addition of organozinc to enones
JP2005518339A (en) Process for producing enantiomerically rich N-acyl-β-amino acid derivatives by enantioselective hydrogenation of the corresponding (Z) enamide
CN115466288B (en) Method for synthesizing selenium/sulfur ligand based on chiral diphosphine ligand
EP1030854A2 (en) Catalysts for asymmetric synthesis containing rigid chiral ligands
Chapsal et al. Catalytic Asymmetric Synthesis With Novel Monodentate Phosphorus Ligands
JPWO2002062809A1 (en) Method for producing ruthenium complex and alcohol compound
Yan et al. Hydroformylation of olefins catalyzed by chiral phosphite-Rh (I) complexes
CN101712697A (en) Ferrocene phosphinimine ligand containing imidazole salt group, preparation thereof and application in catalyzing asymmetric allyl substitution reaction
Yoshizumi et al. Kinetic resolution of racemic acetates by transesterification catalyzed by chiral alkoxocopper (I) complexes

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication